CREDIT SUISSE AG/ - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 179 filers reported holding AXSOME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,004,207
-8.0%
57,293
-5.4%
0.00%0.0%
Q2 2023$4,352,776
+75.4%
60,573
+50.6%
0.00%
+33.3%
Q1 2023$2,480,954
-28.7%
40,223
-10.9%
0.00%
-25.0%
Q4 2022$3,481,803
+26.7%
45,142
-26.7%
0.00%
+33.3%
Q3 2022$2,749,000
+98.3%
61,616
+70.2%
0.00%
+200.0%
Q2 2022$1,386,000
-27.5%
36,203
-21.6%
0.00%
-50.0%
Q1 2022$1,911,000
-58.6%
46,159
-62.2%
0.00%0.0%
Q4 2021$4,619,000
+42.2%
122,243
+24.0%
0.00%0.0%
Q3 2021$3,249,000
+37.1%
98,582
+180.6%
0.00%
+100.0%
Q2 2021$2,369,000
+7.7%
35,127
-9.5%
0.00%0.0%
Q1 2021$2,199,000
-25.8%
38,833
+6.8%
0.00%0.0%
Q4 2020$2,963,000
+85.2%
36,370
+62.0%
0.00%0.0%
Q3 2020$1,600,000
-28.4%
22,452
-17.3%
0.00%
-50.0%
Q2 2020$2,234,000
+140.7%
27,148
+72.0%
0.00%
+100.0%
Q1 2020$928,000
-77.9%
15,780
-61.1%
0.00%
-66.7%
Q4 2019$4,193,000
+1030.2%
40,567
+121.4%
0.00%
Q3 2019$371,000
-35.3%
18,322
-17.7%
0.00%
-100.0%
Q2 2019$573,000
+516.1%
22,265
+31.3%
0.00%
Q2 2017$93,00016,9530.00%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 788,263$35,172,00044.43%
Fairmount Funds Management LLC 1,896,647$84,628,00014.88%
ACT CAPITAL MANAGEMENT, LLC 73,000$3,257,0004.50%
Ghost Tree Capital, LLC 300,000$13,386,0003.76%
Ikarian Capital, LLC 407,600$18,188,0003.62%
Paradigm Biocapital Advisors LP 520,080$23,206,0003.09%
MORGAN JESS S & CO INC 78,895$3,520,0003.06%
PFM Health Sciences, LP 1,659,733$74,057,0002.68%
RTW INVESTMENTS, LP 1,882,164$83,982,0001.94%
Ghost Tree Capital, LLC 150,000$6,693,0001.88%
View complete list of AXSOME THERAPEUTICS INC shareholders